Literature DB >> 24088641

Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.

Manju Jayaraman, Rashmin Anilkumar Gandhi, Priya Ravi, Parveen Sen1.   

Abstract

PURPOSE: To investigate the effect of optic neuritis (ON), ischemic optic neuropathy (ION) and compressive optic neuropathy (CON) on multifocal visual evoked potential (mfVEP) amplitudes and latencies, and to compare the parameters among three optic nerve disorders.
MATERIALS AND METHODS: mfVEP was recorded for 71 eyes of controls and 48 eyes of optic nerve disorders with subgroups of optic neuritis (ON, n = 21 eyes), ischemic optic neuropathy (ION, n = 14 eyes), and compressive optic neuropathy (CON, n = 13 eyes). The size of defect in mfVEP amplitude probability plots and relative latency plots were analyzed. The pattern of the defect in amplitude probability plot was classified according to the visual field profile of optic neuritis treatment trail (ONTT).
RESULTS: Median of mfVEP amplitude (log SNR) averaged across 60 sectors were reduced in ON (0.17 (0.13-0.33)), ION (0.14 (0.12-0.21)) and CON (0.21 (0.14-0.30)) when compared to controls. The median mfVEP relative latencies compared to controls were significantly prolonged in ON and CON group of 10.53 (2.62-15.50) ms and 5.73 (2.67-14.14) ms respectively compared to ION group (2.06 (-4.09-13.02)). The common mfVEP amplitude defects observed in probability plots were diffuse pattern in ON, inferior altitudinal defect in ION and temporal hemianopia in CON eyes.
CONCLUSIONS: Optic nerve disorders cause reduction in mfVEP amplitudes. The extent of delayed latency noted in ischemic optic neuropathy was significantly lesser compared to subjects with optic neuritis and compressive optic neuropathy. mfVEP amplitudes can be used to objectively assess the topography of the visual field defect.

Entities:  

Mesh:

Year:  2014        PMID: 24088641      PMCID: PMC4061667          DOI: 10.4103/0301-4738.118452

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  42 in total

Review 1.  Multifocal VEP and ganglion cell damage: applications and limitations for the study of glaucoma.

Authors:  Donald C Hood; Vivienne C Greenstein
Journal:  Prog Retin Eye Res       Date:  2003-03       Impact factor: 21.198

Review 2.  Electrophysiological assessment of optic nerve disease.

Authors:  G E Holder
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

3.  Improvement in conduction velocity after optic neuritis measured with the multifocal VEP.

Authors:  E Bo Yang; Donald C Hood; Chris Rodarte; Xian Zhang; Jeffrey G Odel; Myles M Behrens
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

Review 4.  Optic neuropathies for the neurologist.

Authors:  V A Purvin
Journal:  Semin Neurol       Date:  2000       Impact factor: 3.420

5.  Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?

Authors:  Darcy H Wolsey; Scott A Larson; Donnel Creel; Robert Hoffman
Journal:  J AAPOS       Date:  2006-08       Impact factor: 1.220

6.  A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter.

Authors:  R W Beck; T J Bergstrom; P R Lichter
Journal:  Ophthalmology       Date:  1985-01       Impact factor: 12.079

7.  Normative ranges and specificity of the multifocal VEP.

Authors:  Brad Fortune; Xian Zhang; Donald C Hood; Shaban Demirel; Chris A Johnson
Journal:  Doc Ophthalmol       Date:  2004-07       Impact factor: 2.379

8.  Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial.

Authors:  J L Keltner; C A Johnson; J O Spurr; R W Beck
Journal:  Arch Ophthalmol       Date:  1994-07

9.  Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy.

Authors:  Joseph F Rizzo; Christopher M Andreoli; James D Rabinov
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

Review 10.  Approach to optic neuropathies: clinical update.

Authors:  Sashank Prasad; Nicholas J Volpe; Laura J Balcer
Journal:  Neurologist       Date:  2010-01       Impact factor: 1.398

View more
  6 in total

1.  Exploring the methods of data analysis in multifocal visual evoked potentials.

Authors:  L Malmqvist; L De Santiago; C Fraser; A Klistorner; S Hamann
Journal:  Doc Ophthalmol       Date:  2016-06-16       Impact factor: 2.379

2.  Comparison of multifocal visual evoked potential, static automated perimetry, and optical coherence tomography findings for assessing visual pathways in patients with pituitary adenomas.

Authors:  Nidan Qiao; Yichao Zhang; Zhao Ye; Ming Shen; Xuefei Shou; Yongfei Wang; Shiqi Li; Min Wang; Yao Zhao
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

3.  Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study.

Authors:  Yi Shao; Feng-Qin Cai; Yu-Lin Zhong; Xin Huang; Ying Zhang; Pei-Hong Hu; Chong-Gang Pei; Fu-Qing Zhou; Xian-Jun Zeng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-11       Impact factor: 2.570

4.  Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study.

Authors:  Xin Huang; Feng-Qin Cai; Pei-Hong Hu; Yu-Lin Zhong; Ying Zhang; Rong Wei; Chong-Gang Pei; Fu-Qing Zhou; Yi Shao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-16       Impact factor: 2.570

5.  A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings.

Authors:  Luis de Santiago; E M Sánchez Morla; Miguel Ortiz; Elena López; Carlos Amo Usanos; M C Alonso-Rodríguez; R Barea; Carlo Cavaliere-Ballesta; Alfredo Fernández; Luciano Boquete
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

Review 6.  Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Authors:  Oliver R Marmoy; Suresh Viswanathan
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 3.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.